Covid-19 Data Science

The occurrence of nursing home deaths after SARS-CoV-2 vaccination has created quite a stir, causing Norway to reconsider whether to...

Peter Doshi has written a piece in the opinion section for the British Medical Journal (BMJ), for which he is an associate editor,...

On social media, it was inevitable that we would start to see anecdotal reports of serious medical conditions experienced after taking a...

Given this article is somewhat long and involved, I first summarize its key points: A new SARS-CoV-2 variant has emerged and taken over...

A paper just published in Nature Communications yesterday measured neutralizing antibody levels in 195 individuals with PCR confirmed...

Derek Lowe writes a column in Science Translational Medicine each week that I have found to be informative and readable, and this week...

Dr Fauci is one of the national leaders in the pandemic, but occasionally he says things that I have really disagreed with. One of these...

Summary of key points: We will soon have 2 approved vaccines providing enough doses for >40% of the nation, but given there is no...

Today we received full data from both the Pfizer/BioNTech Phase 3 vaccine study and the Astrazeneca/Oxford vaccine trials that were...

Moderna just announced the final efficacy results from its Phase 3 study for the SARS-CoV-2 vaccine are complete, and they are...

(Note: I have updated this post on 11/24 based on additional relevant trial information, but the conclusion from the original blog post...

This article in USA Today discusses the new mRNA vaccine technology underlying the Moderna and BioNTech/Pfizer vaccines with my Penn...

The Atlantic published an informative article discussing the mRNA vaccines developed by BioNTech/Pfizer and Moderna and what makes them...

I can't emphasize enough how positive these vaccine trial results are from the Moderna and BioNTech/Pfizer mRNA vaccines, showing much...

Last week, as I highlighted in my blog post, BioNTech/Pfizer released the interim analysis of their phase 3 study results for their...

Biostatistician Natalie Dean and Epidemiologist Marc Lipsitch, key international experts in vaccine studies, just published an article in...

My collaborator and leader of PolicyLab, David Rubin, was on Fox29 Philadelphia this morning for an extended time explaining why he...

Pfizer has a press release on an interim analysis from their SARS-CoV-2 vaccine trial. Here is a link to an NPR article on the release. ...

This study, just published in Clinical Infectious Diseases on Wednesday, presents antibody test results for >2500 healthcare workers and...

With all the arguing about "herd immunity" vs. lockdowns, and with Europe surging and lockdowns starting again in France and Germany, I...